Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Periodontol ; 77(5): 826-31, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16671875

RESUMO

BACKGROUND: Several studies have shown that sectioning bundles of collagen fibers in the marginal gingiva during surgical procedures in animals is a distinct stimulus for alveolar bone resorption. Normally, gingival and periodontal fibroblasts, which reside on these collagen fibers, create physiological traction forces generated by the cytoskeleton. By splitting the fibers, traction forces are released, inducing changes in the cytoskeleton and cell shape. In this study, four drugs were selected, including cytochalasin D, EDTA, sodium orthovanadate, and H-7, all influencing the cytoskeleton-integrin-extracellular matrix (ECM) pathway, for their ability to reduce alveolar bone loss by local application. METHODS: The drugs were applied locally only once at the site of mucoperiosteal flap surgery in a rat model. Cytochalasin D (1 microl/microl), EDTA (0.24 mg/microl), sodium orthovanadate (0.02 mg/microl), and H-7 (0.10 microl/microl), each separately, were carried by a protective paste and placed immediately after elevating the flap. The analysis of alveolar bone loss was performed 3 weeks after surgery by scanning the microradiographic films of the mandible cross-sections. The percentages of cross sections with no, moderate, or severe bone loss in treated in comparison to non-treated rats are presented. RESULTS: EDTA, sodium orthovanadate, and H-7 were significantly effective in reducing alveolar bone loss. They were effective in reducing the amount of severe bone loss by 53%, 20%, and 58% while increasing the number of sections with no bone loss by 25%, 23%, and 35%, respectively. Cytochalasin D reduced alveolar bone loss insignificantly. CONCLUSION: EDTA, sodium orthovanadate, and H-7 are effective in reducing alveolar bone loss in rats following mucoperiosteum surgery.


Assuntos
Perda do Osso Alveolar/tratamento farmacológico , Citoesqueleto/efeitos dos fármacos , Doenças Mandibulares/tratamento farmacológico , Doenças Maxilares/tratamento farmacológico , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina/uso terapêutico , Perda do Osso Alveolar/prevenção & controle , Análise de Variância , Animais , Quelantes/uso terapêutico , Citocalasina D/uso terapêutico , Ácido Edético/uso terapêutico , Inibidores Enzimáticos/uso terapêutico , Masculino , Doenças Mandibulares/prevenção & controle , Doenças Maxilares/prevenção & controle , Inibidores da Síntese de Ácido Nucleico/uso terapêutico , Ratos , Ratos Wistar , Vanadatos/uso terapêutico
3.
Calcif Tissue Int ; 53(3): 217-21, 1993 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8242476

RESUMO

The osteoclastic cytoskeleton has been demonstrated to be composed of microfilaments. Osteoclastic multinucleated cells were suspended on dentine slices and cultured for 24 hours in the presence or absence of cytochalasin D (CD), a specific and potent inhibitor of actin filament elongation to determine the role of this cytoskeleton. Cultured cells and co-cultured dentine slices were examined ultrastructurally. Unlike those in control cultures without CD, osteoclasts in CD-treated cultures became spherical in shape and lacked microvilli on their basolateral cell surfaces. Most importantly, CD treatment induced a complete disappearance of the ruffled border-clear zone complexes in osteoclasts, which resulted in loss of osteoclast-cytoplasmic polarity. Morphometric analysis of backscattered electron micrographs of co-cultured dentine slices revealed that CD treatment strongly inhibited the formation of resorption lacunae in a dose-dependent manner. These results suggest that the cytoarchitecture, as well as the bone-resorbing function, of the osteoclast is highly regulated by the F-actin-containing microfilamentous cytoskeleton in the ruffled border-clear zone complex.


Assuntos
Reabsorção Óssea/tratamento farmacológico , Citocalasina D/farmacologia , Osteoclastos/efeitos dos fármacos , Actinas/metabolismo , Animais , Membrana Celular/efeitos dos fármacos , Membrana Celular/ultraestrutura , Células Cultivadas , Citocalasina D/uso terapêutico , Camundongos , Microscopia Eletrônica de Varredura , Microvilosidades/efeitos dos fármacos , Microvilosidades/ultraestrutura , Osteoclastos/metabolismo , Osteoclastos/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA